Energy News / Shareholders Foundation, Inc.

NASDAQ:SGYP Shareholder Notice: Deadline on April 12, 2019 in Lawsuit Against Synergy Pharmaceuticals Inc

Via: ReleaseWire

Updated 11:30 AM CDT, Tue, April 09,2019

A Deadline is coming up on April 12, 2019 in the lawsuit for investors in Synergy Pharmaceuticals Inc (NASDAQ: SGYP) and NASDAQ: SGYP stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 04/09/2019 -- The Shareholders Foundation announces that a deadline is coming up on April 12, 2019 in the lawsuit filed for certain investors of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) over alleged securities laws violations by Synergy Pharmaceuticals Inc .

Investors who purchased shares of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) have certain options and there are strict and short deadlines running. Deadline: April 12, 2019. NASDAQ: SGYP stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) common shares between September 7, 2017 through October 25, 2018,, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the defendants violated the Securities Exchange Act of 1934 by misrepresenting and/or failing to disclose that the Company's launch of its primary product TRULANCE was not as successful as represented and as a result, revenues from TRULANCE underwhelmed, that Synergy faced substantial risk that it would not be able to satisfy various covenants in its senior secure loan from CRG Partners III L.P. ("CRG") due to the Company's poor launch of TRULANCE and its underwhelming performance, that Synergy's relationship with CRG had soured and CRG was no longer willing to collaborate or be flexible with respect to requirements of the senior secure loan; and that the Company's strategic review had failed to yield a "white knight" or financing alternative and as a result, the Company was likely to default and enter into bankruptcy.

Those who purchased shares of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqsgyp-shareholder-notice-deadline-on-april-12-2019-in-lawsuit-against-synergy-pharmaceuticals-inc-1191326.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com